Sarah Fitzpatrick, Adiel Kaplan and Didi Martinez
  Seeking to ramp up the nation’s capacity to administer a possible COVID-19 vaccine, the Trump administration has signed a $138 million deal with the makers of an innovative syringe designed to be used in developing countries.
  The goal of the public-private initiative, called Project Jumpstart, is to facilitate the production of 100 million prefilled syringes by the end of 2020 and more than 500 million in 2021 in the event a vaccine becomes available, officials announced Tuesday.
  The Health and Human Services Department and the Defense Department are partnering with ApiJect Systems America, which manufactures inexpensive prefilled syringes made of plastic.
  Read the full story here . 
 